or Try an Advanced Search...

    Technical Analysis for MNKD - MannKind Corporation

    Grade Last Price % Change Price Change
    B 6.83 -0.80% -0.06
    MNKD closed up 0.29 percent on Wednesday, November 20, 2024, on 84 percent of normal volume.
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical MNKD trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish -0.80%
    NR7 Range Contraction -0.51%
    NR7-2 Range Contraction -0.51%
    Stochastic Reached Oversold Weakness -0.51%
    Oversold Stochastic Weakness -0.51%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.56%
    NR7 Range Contraction 1.56%
    Inside Day Range Contraction 1.56%
    Gapped Up Strength 1.56%
    Fell Below 20 DMA Bearish 0.37%
    Older End-of-Day Signals for MNKD ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % 9 minutes ago
    Fell Below Previous Day's Low 23 minutes ago
    Down 1% 23 minutes ago
    2x Volume Pace 41 minutes ago
    1.5x Volume Pace 41 minutes ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MNKD Chart by TradingView
    Basic chart:

    Profile

    MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Organ Systems Boat Diabetes Therapeutic Products Endocrine System Insulin Hyperglycemia Inhaler

    Is MNKD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 9 MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 8 Q3 2024 MannKind Corp Earnings Call
    Nov 8 MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
    Nov 8 MannKind (MNKD) Q3 2024 Earnings Call Transcript
    Nov 8 MannKind Corporation (MNKD) Q3 2024 Earnings Conference Call Transcript
    Nov 8 MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say
    Nov 7 MannKind (MNKD) Matches Q3 Earnings Estimates
    Nov 7 MannKind: Q3 Earnings Snapshot
    Nov 7 MannKind Non-GAAP EPS of $0.06 beats by $0.03, revenue of $70.08M misses by $4.41M
    Nov 7 MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
    See more MNKD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.63
    52 Week Low 3.17
    Average Volume 2,288,897
    200-Day Moving Average 5.28
    50-Day Moving Average 6.68
    20-Day Moving Average 7.00
    10-Day Moving Average 7.03
    Average True Range 0.30
    RSI (14) 50.25
    ADX 20.2
    +DI 22.55
    -DI 24.49
    Chandelier Exit (Long, 3 ATRs) 6.73
    Chandelier Exit (Short, 3 ATRs) 7.20
    Upper Bollinger Bands 7.52
    Lower Bollinger Band 6.48
    Percent B (%b) 0.39
    BandWidth 14.89
    MACD Line 0.08
    MACD Signal Line 0.14
    MACD Histogram -0.067
    Fundamentals Value
    Market Cap 1.85 Billion
    Num Shares 270 Million
    EPS -0.12
    Price-to-Earnings (P/E) Ratio -57.33
    Price-to-Sales 5.36
    Price-to-Book 0.00
    PEG Ratio -0.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.24
    Resistance 3 (R3) 7.25 7.15 7.18
    Resistance 2 (R2) 7.15 7.05 7.14 7.16
    Resistance 1 (R1) 7.01 7.00 7.00 7.00 7.14
    Pivot Point 6.91 6.91 6.90 6.90 6.91
    Support 1 (S1) 6.77 6.81 6.76 6.76 6.62
    Support 2 (S2) 6.67 6.76 6.66 6.60
    Support 3 (S3) 6.53 6.67 6.58
    Support 4 (S4) 6.52